Hydrogenology
Source-linked study record

Molecular hydrogen protects against oxidative stress-induced SH-SY5Y neuroblastoma cell death through the process of mitohormesis

Murakami Y, Ito M, Ohsawa I. · PLOS ONE. 2017;12(5):e0176992.

PreclinicalOther formsPublished 2017Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Preclinical

Population or model

Human SH-SY5Y neuroblastoma cells cultured in glucose- or galactose-containing media.

Intervention and dose

Pretreatment or post-treatment in sealed culture boxes with gas containing 1–50% H₂, principally 50% for up to 18 hours, around hydrogen-peroxide exposure. · Boxes were filled at 1 L/min for 30 minutes and then sealed. At 50% H₂, the fill stream contained 500 mL/min H₂ and 100 mL/min O₂; these are filling flows, not continuous 18-hour exposure flows. Medium H₂ was 390±40 μM.

Duration

30-minute box fill followed by sealed exposures from one to 18 hours; oxidative-stress outcome timing varied by assay.

Reported result

H₂ pretreatment of at least three hours reduced later hydrogen-peroxide cell death and changed mitochondrial and Nrf2-linked measures. Post-treatment did not protect; mitochondrial DNA copy number did not change, DCFDA-indicated ROS did not increase, and the induced stress included lower glutathione and higher superoxide in one metabolic condition.

Main limitation

Cancer-derived cell line, high gas concentrations, sealed-box exposure, small laboratory replicate counts, pretreatment paradigm and many mechanistic endpoints. Japanese public grants funded the work; authors declared no competing interests.

Evidence and classification

What kind of evidence is this?

Evidence type

Preclinical

Reported design

Controlled SH-SY5Y neuroblastoma-cell gas-exposure and oxidative-stress experiment

Research topic

Other neurological conditions

Administration form

Other forms

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

Human SH-SY5Y neuroblastoma cells cultured in glucose- or galactose-containing media.

Sample

Experiments were repeated two or three times with n=4–5 per group; selected protein measurements used n=5–6.

Duration

30-minute box fill followed by sealed exposures from one to 18 hours; oxidative-stress outcome timing varied by assay.

Intervention

Pretreatment or post-treatment in sealed culture boxes with gas containing 1–50% H₂, principally 50% for up to 18 hours, around hydrogen-peroxide exposure.

Hydrogen form

50% H₂ with 10% O₂, 5% CO₂ and 35% N₂ — H₂ alone as the active gas component, not Brown's gas.

Dose or H₂ specification

Boxes were filled at 1 L/min for 30 minutes and then sealed. At 50% H₂, the fill stream contained 500 mL/min H₂ and 100 mL/min O₂; these are filling flows, not continuous 18-hour exposure flows. Medium H₂ was 390±40 μM.

Comparator

Matched 10% O₂/5% CO₂/85% N₂ gas without H₂, multiple H₂ concentrations/durations and pretreatment versus post-treatment.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Cell death, mitochondrial membrane potential, ATP, oxygen consumption, mitochondrial DNA, glutathione/superoxide/ROS and Nrf2-pathway gene/protein expression.

Reported result

H₂ pretreatment of at least three hours reduced later hydrogen-peroxide cell death and changed mitochondrial and Nrf2-linked measures. Post-treatment did not protect; mitochondrial DNA copy number did not change, DCFDA-indicated ROS did not increase, and the induced stress included lower glutathione and higher superoxide in one metabolic condition.

Extraction completeness

The complete free PMC article, figures and gas-system methods were checked for exact mixture and filling flow, concentration/duration comparisons, positive and null/adverse-direction findings, funding and conflicts.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Cancer-derived cell line, high gas concentrations, sealed-box exposure, small laboratory replicate counts, pretreatment paradigm and many mechanistic endpoints. Japanese public grants funded the work; authors declared no competing interests.

Applies directly to

SH-SY5Y cells under induced oxidative stress; it does not establish neuroprotection or cancer treatment in animals or people.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 28467497 · DOI: 10.1371/journal.pone.0176992

Publisher access

Free full article in PubMed Central.

Extraction basis

Complete PMC article and PubMed metadata; full-text extraction checked 9 August 2026.

Last reviewed

10 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.